Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
83 studies found for:    Alpha-1 Antitrypsin Deficiency
Show Display Options
RSS Create an RSS feed from your search for:
Alpha-1 Antitrypsin Deficiency
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency
Condition: Alpha-1 Antitrypsin Deficiency
Intervention: Other: collection of sputum
2 Completed
Has Results
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
Conditions: Emphysema;   Alpha 1-antitrypsin Deficiency (AATD)
Interventions: Biological: Prolastin-C, 60 mg/kg;   Biological: Prolastin-C, 120 mg/kg
3 Recruiting Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (AATD)
Conditions: Liver Fibrosis;   Alpha-1 Antitrypsin Deficiency;   AAT Deficiency;   AATD
Interventions: Device: Abdominal ultrasound;   Procedure: History and physical;   Procedure: Intravenous catheter;   Procedure: Blood draw;   Other: Liver questionnaire;   Procedure: Liver Biopsy;   Drug: Midazolam;   Drug: Fentanyl;   Drug: Lidocaine;   Drug: Acetaminophen;   Drug: Lorazepam;   Drug: Oxycodone/Acetaminophen;   Drug: Ondansetron
4 Recruiting Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency
Condition: Alpha 1-Antitrypsin Deficiency
Intervention:
5 Recruiting Alpha-1 Antitrypsin Deficiency Adult Liver Study
Condition: Alpha-1 Antitrypsin Deficiency
Intervention: Procedure: Liver Biopsy
6 Recruiting Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Conditions: Alpha-1-antitrypsin Deficiency;   Liver Cirrhosis
Interventions: Drug: Drug-Carbamazepine (Tegretol XR);   Drug: Carbamazepine (Tegretol XR) Placebo
7 Unknown  Endoscopic Lung Volume Reduction in Patients With Advanced Emphysema Due to alpha1 Antitrypsin Deficiency
Condition: Hereditary Emphysema (Alpha 1-antitrypsin Deficiency)
Intervention: Device: Implantation of intrabronchial valves (IBV) (Spiration IBV)
8 Completed Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Alpha-1 Antitrypsin Deficiency;   Chronic Obstructive Pulmonary Disease
Intervention:
9 Enrolling by invitation Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Condition: Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
Intervention: Biological: Alpha-1 MP
10 Completed
Has Results
Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency
Condition: Alpha-1 Antitrypsin Deficiency
Intervention: Drug: rAAV1-CB-hAAT
11 Completed Effects of Exercise Training in Chronic Obstructive Pulmonary Disease Versus Alpha-1-Antitrypsin-deficiency-patients
Conditions: Chronic Obstructive Pulmonary Disease;   Alpha-1-antitrypsin-deficiency
Intervention: Procedure: exercise training
12 Recruiting A Study of ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)
Condition: Alpha-1 Antitrypsin Deficiency
Interventions: Drug: ARC-AAT Injection;   Other: Placebo
13 Completed
Has Results
Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults
Condition: Alpha 1-Antitrypsin Deficiency
Interventions: Drug: Alpha-1 MP;   Drug: alpha-1 proteinase inhibitor (human)
14 Not yet recruiting Safety Study of Gene Transfer Vector to Treat alpha1-antitrypsin Deficiency
Condition: alpha1-antitrypsin Deficiency
Intervention: Genetic: AAVrh.10halpha1AT
15 Completed Genomic Research in Alpha-1 Antitrypsin Deficiency
Conditions: Alpha 1 Antitrypsin Deficiency;   AATD
Intervention:
16 Completed The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency
Condition: Alpha-1 Antitrypsin Deficiency
Intervention:
17 Completed
Has Results
Pharmacokinetic Study of ARALAST (Human Alpha1- PI)
Condition: Alpha 1-Antitrypsin Deficiency
Interventions: Biological: Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor;   Biological: Dose of 60 mg/kg alpha1-proteinase inhibitor
18 Completed Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
Condition: Alpha 1-antitrypsin Deficiency
Intervention: Drug: Aerosolized, Recombinant Alpha 1-Antitrypsin
19 Recruiting Stage 1 Study of ARALAST NP and GLASSIA in A1PI
Conditions: Chronic Obstructive Pulmonary Disease;   Alpha1-antitrypsin Deficiency
Interventions: Biological: ARALAST NP 60 mg/kg;   Biological: ARALAST NP 120 mg/kg;   Biological: GLASSIA 60 mg/kg;   Biological: GLASSIA 120 mg/kg;   Biological: Human Albumin 2%
20 Completed
Has Results
Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Conditions: Emphysema;   Alpha 1-proteinase Inhibitor Deficiency
Intervention: Biological: Alpha1- proteinase inhibitor [human]

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years